The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Panel to leverage their collective expertise to create monthly and annual reports to explore future contingencies effecting the global pharma industry
read more
EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, and Plasticell of London, UK, today announced the availability of ...
read more
25 April 2013: Malvern, UK: Malvern Instruments is joining forces with contract services organization Next Breath, which specializes in inhaled ...
read more
Wednesday, April 17, 2013
Contributing to the Analytical and Purification Streams at the protein engineering summit PEGS 2013, Dr Kevin Mattison, Principal Scientist, ...
read more
Pharmaceutical developers at Synthon, a global specialist in the development and manufacture of generic medicines, have chosen an Optim 1000 high ...
read more
Wednesday, January 30, 2013
Natoli Engineering and the Arnold and Marie Schwartz College of Pharmacy and Health Sciences at Long Island University (LIU) are pleased to announce a...
read more
Friday, November 30, 2012
A recent experimental study demonstrates the ability of the Morphologi G3-ID particle characterization system from Malvern Instruments to efficiently ...
read more
Friday, November 30, 2012
The Chairman of Erich NETZSCH GmbH & Co. Holding KG, Dr. Otto Max Schaefer, resigns as Chairman as of December 31, 2012 on his own request and on the ...
read more
Wednesday, October 31, 2012
Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, today announced that it has...
read more
Aptalis Pharmaceutical Technologies, formerly Eurand, focused on developing differentiated oral products utilizing its pharmaceutical technologies, ...
read more
Mayne Pharma Group Limited (“Mayne Pharma”), a publicly held company based in Melbourne, Australia, is pleased to announce that it has entered into a ...
read more
Friday, September 07, 2012
FDA approvals, revenue gain and organic business growth are just a few of the topics that John Fraher, President, Aptalis Pharma, addresses during an ...
read more
TSI is pleased to announce the release of its YouTube Channel, TSICorporate. Designed to bring additional value to customers and the marketplace, the ...
read more
Catalent announced it has commenced supply to Otsuka Pharmaceutical Co., Ltd. of Abilify® OD Tablets (orally disintegrating tablets (ODT)), which ...
read more
Aptalis Pharmaceutical Technologies, a business unit of Aptalis Pharma that focuses on developing differentiated oral products utilizing its ...
read more